CIK: 0001882053 · Show all filings
Period: Q4 2022 (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $194,883 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UNM | UNUM GROUP | 671,530 | $27,553 | 14.1% | $41.90 | 0.0% | COM | 91529Y106 |
| CI | CIGNA CORP NEW | 59,029 | $19,559 | 10.0% | $298.87 | 0.0% | COM | 125523100 |
| LLY | LILLY ELI & CO | 47,448 | $17,358 | 8.9% | $345.79 | 0.0% | COM | 532457108 |
| ENOV | ENOVIS CORPORATION | 276,246 | $14,785 | 7.6% | $51.61 | 0.0% | COM | 194014502 |
| DHR | DANAHER CORPORATION | 54,356 | $14,427 | 7.4% | $228.13 | 0.0% | COM | 235851102 |
| OGN | ORGANON & CO | 498,262 | $13,916 | 7.1% | $21.97 | 0.0% | COMMON STOCK | 68622V106 |
| MOH | MOLINA HEALTHCARE INC | 39,444 | $13,025 | 6.7% | $339.69 | 0.0% | COM | 60855R100 |
| ABT | ABBOTT LABS | 112,106 | $12,308 | 6.3% | $97.62 | 0.0% | COM | 002824100 |
| ABBV | ABBVIE INC | 75,873 | $12,262 | 6.3% | $137.22 | 0.0% | COM | 00287Y109 |
| BIIB | BIOGEN INC | 41,843 | $11,587 | 5.9% | $282.44 | 0.0% | COM | 09062X103 |
| MDRX | VERADIGM INC | 600,000 | $10,584 | 5.4% | $16.75 | 0.0% | COM | 01988P108 |
| — | APOLLO ENDOSURGERY INC | 718,419 | $7,163 | 3.7% | $9.97 | — | COM | 03767D108 |
| QTRX | QUANTERIX CORP | 490,225 | $6,790 | 3.5% | $11.51 | 0.0% | COM | 74766Q101 |
| TBRG | COMPUTER PROGRAMS & SYS INC | 227,365 | $6,189 | 3.2% | $28.56 | 0.0% | COM | 205306103 |
| — | AFFIMED N V | 2,869,744 | $3,558 | 1.8% | $1.24 | — | COM | N01045108 |
| CABA | CABALETTA BIO INC | 266,882 | $2,469 | 1.3% | $3.64 | 0.0% | COM | 12674W109 |
| — | CARDIOVASCULAR SYS INC DEL | 99,157 | $1,351 | 0.7% | $13.62 | — | COM | 141619106 |